Announced
Completed
Financials
Tags
Completed
Private Equity
Private
Acquisition
Domestic
Biotechnology
United States
Friendly
Single Bidder
Majority
Synopsis
Graham Partners, a private equity firm, completed an investment in Rhythmlink, a medical device manufacturing company. Financial terms were not disclosed. “We’re excited about this next phase of Rhythmlink. Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities. I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics,” Shawn Regan, Graham CEO and Co-Founder.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.